Wall Street Journal, February 10, 2009

Pfizer Inc. has announced that it will become the latest drug maker to publicly disclose the payments it makes to doctors. Pfizer will report all payments to doctors of more than $500 for consulting and speaking arrangements and will also make public the money it pays them to participate in its clinical trials. Federal legislation could soon mandate such transparency from the entire industry.

Facebook icon
LinkedIn icon
Twitter icon